What are the suggested peak target ranges for several LMWHs?
The suggested peak target ranges for several LMWHs are shown in Table 6. With enoxaparin, anti-Xa activity is increased to appropriate levels when the drug is administered to obese patients in doses based on total body weight up to a weight of 144 kg.141 The same is true for dalteparin142,143 and tinzaparin144 in patients weighing up to 190 and 165 kg, respectively.